Merck KGaA
Merck KGaA appoints new heads of corporate auditing and strategy
December 2, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA
Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …
Merck and Merck look to settle Facebook naming dispute
November 29, 2011Medical Communications Facebook, Merck, Merck KGaA
Merck & Co and Merck KGaA looked to have made inroads into their Facebook naming quarrel. Earlier this month Merck …
Joachim Christ to lead corporate controlling at Merck KGaA
November 15, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA
Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …
Merck KGaA signs MS and cancer research deal
October 5, 2011Research and Development Merck KGaA
Merck KGaA has signed development deals with Japanese firm Ono Pharmaceutical Co around two investigational treatments, one for multiple sclerosis …
Merck licences new MS drug
September 19, 2011Research and Development Cladribine, Merck KGaA, Merck Serono, PI-2301
Merck KGaA has in-licensed a new multiple sclerosis drug and aims to start it in phase II studies later this …
Merck acquires cell imaging instrument maker Amnis
September 1, 2011Research and Development Merck KGaA, Millipore
EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …
Merck scraps MS pill cladribine
June 23, 2011Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis
Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …
Merck KGaA readies phase III brain cancer trial
June 13, 2011Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma
Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …
Merck KGaA sells South African manufacturing unit
May 10, 2011Manufacturing and Production Merck KGaA, Merck Pharmaceutical Manufacturing, Merck South Africa
Merck South Africa, a subsidiary of Germany’s Merck KGaA, has sold its manufacturing to a local private equity firm as …
Merck re-submits Erbitux to the EMA for lung cancer
March 30, 2011Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer
Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …
FDA knocks back Merck KGaA’s oral MS drug
March 2, 2011Sales and Marketing Cladribine, EMD Serono, FDA, MS, Merck KGaA, Movectro, multiple sclerosis, oral MS drugs
US authorities have turned down Merck KGaA’s new drug application for its oral relapsing-remitting multiple sclerosis treatment Movectro. The FDA …
Friedhelm Felten to head procurement at Merck
March 1, 2011Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development
Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …
Merck KGaA sales soar
February 21, 2011Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro
Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
Merck Serono halts Movectro European licence application
February 18, 2011Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis
Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
Germany’s Merck pledges emphasis on women executives
February 14, 2011Sales and Marketing Merck KGaA, Women in pharma, equality
Merck KGaA has set itself the goal of increasing its proportion of women managers over the next five years. The …
